馬保健市場規模、份額和趨勢分析報告:按產品(藥物、疫苗)、適應症、活動、分銷渠道、地區、細分市場預測 2022-2030 年
市場調查報告書
商品編碼
1147601

馬保健市場規模、份額和趨勢分析報告:按產品(藥物、疫苗)、適應症、活動、分銷渠道、地區、細分市場預測 2022-2030 年

Equine Healthcare Market Size, Share & Trends Analysis Report By Product (Pharmaceuticals, Vaccines), By Indication, By Activity, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

馬匹健康管理市場的增長和趨勢

根據 Grand View Research, Inc. 的最新報告,到 2030 年,全球馬匹保健市場預計將達到 43.7 億美元。從 2022 年到 2030 年,該市場預計將以 6.1% 的複合年增長率增長。產品研發的增加、對馬診斷的需求、主要行業利益相關者的投資、馬疾病患病率上升等是推動市場增長的一些關鍵因素。例如,2021 年 9 月,美國農業部在動物營養和健康方面投資了約 30 億美元。

COVID-19 大流行對賽馬/體育行業產生了特別顯著的影響。馬匹護理服務的減少導致馬術表演被取消。由於 COVID-19,所有教育、培訓、比賽、活動、旅遊相關和娛樂活動都已取消。賽馬在全球範圍內受到影響,對馬廄的需求減少。瑞典是歐盟唯一一個繼續賽馬的國家。法國馬業集群Hippolia進行的一項調查發現,68.8%的受訪者認為無法彌補缺口,所有馬術比賽都已取消。運動馬的損失總額估計為 3.8589 億美元。然而,放寬限制措施和改善馬匹醫療保健的可及性將使市場在 2021 年復甦。

技術進步、研究和開發以及市場參與者在馬匹診斷方面不斷增加的舉措是推動市場發展的主要因素。例如,根據美國獸醫協會 2022 年 7 月發表的一篇文章,一項研究評估了專有的基於螺旋扇束 CT 的診斷性能,該 CT 用於對患有臨床頭頸並發症的馬進行成像。總共包括 120 多匹馬,並審查了在兩家大學醫院接受頭頸部 CT 掃描的馬的病歷。年齡、性別、品種、主訴、鎮靜劑劑量、手術時間、附加成像技術的使用、成像、臨床診斷和成像相關問題都被記錄下來。該 CT 系統已被證明在馬牙齒和鼻竇的常規成像中具有短期和可靠的實用性。

此外,馬類疾病的增加也是推動市場增長的因素之一。例如,西尼羅河病毒於 2022 年 9 月被加利福尼亞州食品和農業部確認在稻田的一頭來自內華達縣的 10 歲未接種疫苗的誇特馬種馬呈陽性反應,該種馬錶現出短暫的發燒和神經系統症狀。這是 2022 年在加利福尼亞州確認的第八例馬 WNV 病例。其他六個縣也確認了陽性病例:克恩 3 個,內華達州 1 個,薩克拉門托 1 個,聖路易斯奧比斯波 1 個,特哈馬 1 個,丘利亞 3 個。預計未來對馬類疾病的認識會提高,及時接種疫苗的需求也會增加。

馬匹健康管理市場報告要點

按產品劃分,2021年醫藥板塊佔比將超過30.0%,滲透率高、應用廣泛,將佔據市場主導地位

其他產品領域,包括再生醫學和乾細胞治療解決方案,預計在預測期內增長最快

根據指示,寄生蟲控制將在 2021 年佔據最大份額,超過 20.0%。這是由於對控制內部和外部寄生蟲的有效殺寄生蟲劑的需求不斷增長

體育/賽車活動領域預計將在 2021 年以超過 40.0% 的收入份額主導市場,在預測期內以最快的速度增長

從分銷渠道來看,動物醫院和診所在 2021 年所佔份額最大。電子商務領域預計在預測期內以最快的複合年增長率增長

北美和歐洲在 2021 年佔據了顯著份額。由於馬術比賽/體育行業的發展,預計亞太地區在預測期內將呈現良好增長。

內容

第 1 章調查方法及範圍

  • 市場細分和範圍
    • 估計/預測時間表
  • 調查方法
  • 資訊採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要資訊
    • 初步調查
    • 初步調查的詳細資訊
  • 資訊或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細資訊
  • 二級資訊列表

第 2 章執行摘要

  • 市場展望
  • 細分市場展望

第 3 章馬保健市場可變趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 輔助市場展望
  • 按適應症繪製滲透率和增長前景,2021 年
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 行業分析 - 搬運工
    • 波特的分析
      • 供應商的議價能力
      • 買家的議價能力
      • 替代品的威脅
      • 新進入者的威脅
      • 競爭公司之間的敵對關係
    • PESTLE 分析
      • 政治/法律狀況
      • 經濟狀況
      • 社交情況
      • 技術概況
  • 2017-2021 年估計的馬匹數量,按主要國家/地區分類
  • 監管框架和贖回情況
  • 價格分析
  • 主要地區的疾病流行率估計分析
  • 馬匹保健:COVID-19 的影響
    • 當前和未來的影響分析
    • COVID-19 對市場參與者的影響

第 4 章馬保健市場:細分分析,副產品,2017-2030(百萬美元)

  • 2021 年和 2030 年產品市場份額分析
  • 馬保健市場:產品差異分析
  • 疫苗
  • 醫藥
    • 殺寄生蟲劑
    • 抗感染
    • 消炎鎮痛藥
    • 其他
  • 藥用飼料添加劑
  • 診斷
  • 軟件和服務
  • 其他

第 5 章馬保健市場:細分分析,按適應症,2017-2030 年(百萬美元)

  • 2021 年和 2030 年適應症市場份額分析
  • 馬匹健康管理市場:適應症變化分析
  • 肌肉骨骼疾病
  • 寄生蟲控制
  • 內科
  • 馬皰疹病毒
  • 馬腦脊髓炎
  • 馬流感
  • 西尼羅病毒
  • 破傷風
  • 其他

第 6 章馬保健市場:細分分析,按活動,2017-2030 年(百萬美元)

  • 2021 年和 2030 年活動市場份額分析
  • 馬匹健康管理市場:活動變化分析
  • 運動/賽車
  • 娛樂
  • 其他

第 7 章馬保健市場:細分分析,按分銷渠道,2017-2030 年(百萬美元)

  • 2021 年和 2030 年分銷渠道市場份額分析
  • 馬匹健康管理市場:分銷渠道分析波動分析
  • 獸醫醫院和診所
  • 電子商務
  • 其他

第 8 章馬保健市場:區域市場分析、副產品、適應症、活動和分銷渠道 2017-2030(百萬美元)

  • 2021 年和 2030 年區域市場份額分析
  • 區域市場概況
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯

第 9 章馬匹健康管理市場-競爭格局

  • 公司簡介
    • Zoetis
      • 公司簡介
      • 財務業績
      • 產品/服務基準
      • 戰略舉措
    • Boehringer Ingelheim International GmbH
      • 公司簡介
      • 財務業績
      • 產品/服務基準
      • 戰略舉措
    • Ceva
      • 公司簡介
      • 財務業績
      • 產品/服務基準
      • 戰略舉措
    • SOUND
      • 公司簡介
      • 財務業績
      • 產品/服務基準
      • 戰略舉措
    • MERCK & CO., INC.
      • 公司簡介
      • 財務業績
      • 產品/服務基準
      • 戰略舉措
    • Hallmarq Veterinary Imaging
      • 公司簡介
      • 財務業績
      • 產品/服務基準
      • 戰略舉措
    • ESAOTE SPA
      • 公司簡介
      • 財務業績
      • 產品/服務基準
      • 戰略舉措
    • Vetoquinol S.A.
      • 公司簡介
      • 財務業績
      • 產品/服務基準
      • 戰略舉措
    • IDEXX Laboratories, Inc.
      • 公司簡介
      • 財務業績
      • 產品/服務基準
      • 戰略舉措
    • Dechra Pharmaceuticals PLC
      • 公司簡介
      • 財務業績
      • 產品/服務基準
      • 戰略舉措
  • 市場參與分類
  • 公司市場分析 - 熱圖分析
  • 協同分析:主要交易和戰略聯盟
  • 主要公司名單
Product Code: GVR-4-68039-986-8

Equine Healthcare Market Growth & Trends:

The global equine healthcare market size is anticipated to reach USD 4.37 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.1% from 2022 to 2030. Increasing product R&D, demand for equine diagnostics, investments by key industry stakeholders, and the rising prevalence of diseases in horses are some of the major factors contributing to the market growth. For instance, in September 2021, the U.S. Department of Agriculture invested around USD 3.0 billion in the animal nutrition and health sector.

The Covid-19 pandemic had a notable impact, particularly on the horse racing/ sports sector. It led to reduced access to equine care services and the cancelation of equine shows. Teaching, training, competitions, events, tourism-related activities, and recreational activities were all discontinued as a result of COVID-19. Horse racing was adversely impacted across the world, along with the demand for horse boarding. Only Sweden continued to hold races within the EU. According to a survey conducted by Hippolia, French Equine Industry Cluster, 68.8% of respondents believed the recovery of the shortfall is impossible, and all equine competitions have been discontinued. A total of USD 385.89 million in sport horse losses were incurred as per estimates. However, the market recovered in 2021 owing to easing lockdown measures and improved access to equine healthcare.

Growing technological advancement, R&D, and initiatives by market players in equine diagnostics are key factors driving the market. For instance, according to a July 2022 article published by the American Veterinary Medical Association, a study was carried out to assess the diagnostic performance of a unique helical fan beam-based CT utilized for imaging horses with clinical head and neck complications. A total of over 120 horses were involved, and the medical records of those who had undergone head or neck CT scans at two university hospitals were examined. Age, sex, breed, the primary complaint, the amount of sedation utilized, the length of the operation, the use of any further diagnostic imaging techniques, the imaging diagnosis, the clinical diagnosis, and any imaging-related problems were all noted. The CT system proved to have short scanning times and reliable utility for regular imaging of horses' teeth and sinuses.

Furthermore, the rising prevalence of diseases in horses is another factor propelling the market growth. West Nile Virus, for instance, was positively identified in a 10-year-old unvaccinated Quarter Horse stallion in Nevada County who was exhibiting transient fever and neurological symptoms by the California Department of Food and Agriculture in September 2022. This was the 8th confirmed case of the equine WNV in California in 2022. Other positive cases were identified in six counties: three in Kern, one in Nevada, one in Sacramento, one in San Luis Obispo, one in Tehama, and three in Tulare. This is expected to promote awareness regarding equine diseases while fueling demand for timely vaccination of horses.

Equine Healthcare Market Report Highlights:

  • Based on product, the pharmaceuticals segment dominated the market with a share of over 30.0% in 2021 owing to a high uptake and wide availability of these products
  • The others product segment comprising regenerative medicine and stem cell therapy solutions is projected to be the fastest growing segment in the forecast period
  • Based on indication, parasite control held the largest share of over 20.0% in 2021. It is due to the growing demand for effective parasiticides for the control of internal and external parasites
  • The sports/racing activity segment dominated the market with a revenue share of over 40.0% in 2021 and is anticipated to grow at the fastest rate during the forecast period
  • Based on distribution channel, veterinary hospitals and clinics held the largest share in 2021. The e-commerce segment is projected to expand at the fastest CAGR during the forecast period
  • North America and Europe held notable shares in 2021. The Asia Pacific is expected to witness lucrative growth in the forecast period owing to a budding equine racing/ sports sector

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates & Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
  • 1.7 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Equine Healthcare Market Variables Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping by Indication, 2021
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Market Restraint Analysis
  • 3.4 Industry Analysis - Porter's
    • 3.4.1 Porter's Analysis
      • 3.4.1.1 Bargaining Power Of Suppliers
      • 3.4.1.2 Bargaining Power Of Buyers
      • 3.4.1.3 Threat Of Substitutes
      • 3.4.1.4 Threat Of New Entrants
      • 3.4.1.5 Competitive Rivalry
    • 3.4.2 Pestle Analysis
      • 3.4.2.1 Political/Legal Landscape
      • 3.5.2.2 Economic Landscape
      • 3.5.2.3 Social Landscape
      • 3.5.2.4 Technology Landscape
  • 3.5 Estimated Equine Population, 2017 to 2021, by key countries
  • 3.6 Regulatory Framework & Reimbursement Landscape
  • 3.7 Pricing Analysis
  • 3.8 Estimated Disease Prevalence Analysis, By Key Regions
  • 3.9 Equine Healthcare: Covid-19 Impact
    • 3.9.1 Current And Future Impact Analysis
    • 3.9.2 Impact Of Covid-19 On Market Players

Chapter 4 Equine Healthcare Market: Segment Analysis, By Product, 2017 - 2030 (USD Million)

  • 4.1 Product Market Share Analysis, 2021 & 2030
  • 4.2 Equine Healthcare market: Product movement analysis
  • 4.3 Vaccines
    • 4.3.1 Vaccines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.4 Pharmaceuticals
    • 4.4.1 Pharmaceuticals Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 4.4.2 Parasiticides
      • 4.4.2.1 Parasiticides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 4.4.3 Anti-Infectives
      • 4.4.3.1 Anti-Infectives Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 4.4.4 Anti-Inflammatory & Analgesics
      • 4.4.4.1 Anti-Inflammatory & Analgesics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 4.4.5 Others
      • 4.4.5.1 Other Pharmaceuticals Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.5 Medicinal Feed Additives
    • 4.5.1 Medicinal Feed Additives Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.6 Diagnostics
    • 4.6.1 Diagnostics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.7 Software & Services
      • 4.7.1software & Services Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 4.8 Others
    • 4.8.1. Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 5 Equine Healthcare Market: Segment Analysis, By Indication, 2017 - 2030 (USD Million)

  • 5.1 Indication Market Share Analysis, 2021 & 2030
  • 5.2 Equine Healthcare market: Indication movement analysis
  • 5.3 Musculoskeletal Disorders
    • 5.3.1 Musculoskeletal Disorders Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.4 Parasite Control
    • 5.4.1 Parasite Control Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.5 Internal Medicine
    • 5.5.1 Internal Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.6 Equine Herpes Virus
    • 5.6.1 Equine Herpes Virus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.7 Equine Encephalomyelitis
    • 5.7.1 Equine Encephalomyelitis Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.8 Equine Influenza
    • 5.8.1 Equine Influenza Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.9 West Nile Virus
    • 5.9.1 West Nile Virus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.10 Tetanus
    • 5.10.1 Tetanus Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 5.11 Others
    • 5.11.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 6 Equine Healthcare Market: Segment Analysis, By Activity, 2017 - 2030 (USD Million)

  • 6.1 Activity Market Share Analysis, 2021 & 2030
  • 6.2 Equine Healthcare market: Activity movement analysis
  • 6.3 Sports/Racing
    • 6.3.1 Sports/Racing Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 6.4 Recreation
    • 6.4.1 Recreation Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 7 Equine Healthcare Market: Segment Analysis, By Distribution Channel, 2017 - 2030 (USD Million)

  • 7.1 Distribution Channel Market Share Analysis, 2021 & 2030
  • 7.2 Equine Healthcare Market: Distribution Channel Analysis Movement Analysis
  • 7.3 Veterinary Hospitals & Clinics
    • 7.3.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 7.4 E-Commerce
    • 7.4.1 E-Commerce Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 8 Equine Healthcare Market: Regional Market Analysis, By Product, Indication, Activity, and Distribution Channel 2017 - 2030 (USD Million)

  • 8.1 Regional Market Share Analysis, 2021 & 2030
  • 8.2 Regional Market Snapshot
  • 8.3 North America
    • 8.3.1 North America Equine Healthcare Market Estimates And Forecasts By Countries, 2017 - 2030 (USD Million)
    • 8.3.2 U.S.
      • 8.3.2.1 U.S. Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.3.3 Canada
      • 8.3.3.1 Canada Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.4 Europe
    • 8.4.1 Europe Equine Healthcare Market Estimates and Forecasts By Countries, 2017 - 2030 (USD MILLION)
    • 8.4.2 U.K.
      • 8.4.2.1 U.K. Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.4.3 Germany
      • 8.4.3.1 Germany Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.4.4 France
      • 8.4.4.1 France Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.4.5 Italy
      • 8.4.5.1 Italy Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.4.6 Spain
      • 8.4.6.1 Spain Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.5.2 Japan
      • 8.5.2.1 Japan Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.5.3 China
      • 8.5.3.1 China Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.5.4 India
      • 8.5.4.1 India Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.5.5 Australia
      • 8.5.5.1 Australia Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.5.6 South Korea
      • 8.5.6.1 South Korea Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.6 Latin America
    • 8.6.1 Latin America Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.6.2 Brazil
      • 8.6.2.1 Brazil Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.6.3 Mexico
      • 8.6.3.1 Mexico Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
    • 8.6.4 Argentina
      • 8.6.4.1 Argentina Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • 8.7 MEA
    • 8.7.1 MEA Equine Healthcare Market Estimates And Forecasts By Countries, 2017 - 2030 (USD Million)
    • 8.7.2 South Africa
      • 8.7.2.1 South Africa Equine Healthcare Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 8.7.2 Saudi Arabia
      • 8.7.2.1 Saudi Arabia Equine Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 9Equine Healthcare Market - Competitive Landscape

  • 9.1 Company Profiles
    • 9.1.1 Zoetis
      • 9.1.1.1 Company Overview
      • 9.1.1.2 Financial Performance
      • 9.1.1.3 Product/Service Benchmarking
      • 9.1.1.4 Strategic Initiatives
    • 9.1.2 Boehringer Ingelheim International GmbH
      • 9.1.2.1 Company Overview
      • 9.1.2.2 Financial Performance
      • 9.1.2.3 Product/Service Benchmarking
      • 9.1.2.4 Strategic Initiatives
    • 9.1.3 Ceva
      • 9.1.3.1 Company Overview
      • 9.1.3.2 Financial Performance
      • 9.1.3.3 Product/Service Benchmarking
      • 9.1.3.4 Strategic Initiatives
    • 9.1.4 SOUND
      • 9.1.4.1 Company Overview
      • 9.1.4.2 Financial Performance
      • 9.1.4.3 Product/Service Benchmarking
      • 9.1.4.4 Strategic Initiatives
    • 9.1.5 MERCK & CO., INC.
      • 9.1.5.1 Company Overview
      • 9.1.5.2 Financial Performance
      • 9.1.5.3 Product/Service Benchmarking
      • 9.1.5.4 Strategic Initiatives
    • 9.1.6 Hallmarq Veterinary Imaging
      • 9.1.6.1 Company Overview
      • 9.1.6.2 Financial Performance
      • 9.1.6.3 Product/Service Benchmarking
      • 9.1.6.4 Strategic Initiatives
    • 9.1.7 ESAOTE SPA
      • 9.1.7.1 Company Overview
      • 9.1.7.2 Financial Performance
      • 9.1.7.3 Product/Service Benchmarking
      • 9.1.7.4 Strategic Initiatives
    • 9.1.8 Vetoquinol S.A.
      • 9.1.8.1 Company Overview
      • 9.1.8.2 Financial Performance
      • 9.1.8.3 Product/Service Benchmarking
      • 9.1.8.4 Strategic Initiatives
    • 9.1.9 IDEXX Laboratories, Inc.
      • 9.1.9.1 Company Overview
      • 9.1.9.2 Financial Performance
      • 9.1.9.3 Product/Service Benchmarking
      • 9.1.9.4 Strategic Initiatives
    • 9.1.10 Dechra Pharmaceuticals PLC
      • 9.1.10.1 Company Overview
      • 9.1.10.2 Financial Performance
      • 9.1.10.3 Product/Service Benchmarking
      • 9.1.10.4 Strategic Initiatives
  • 9.2 Market Participation Categorization
  • 9.3 Company Market Position Analysis - Heat Map Analysis
  • 9.4 Synergy Analysis: Major Deals & Strategic Alliances
  • 9.5 List of Key Companies

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Key Companies
  • Table 3 North America Equine Healthcare market, by country, 2017 - 2030 (USD Million)
  • Table 4 North America Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 5 North America Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 6 North America Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 7 North America Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 8 U.S. Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 9 U.S. Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 10 U.S. Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 11 U.S. Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 12 Canada Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 13 Canada Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 14 Canada Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 15 Canada Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 16 Europe Equine Healthcare market, by country, 2017 - 2030 (USD Million)
  • Table 17 Europe Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 18 Europe Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 19 Europe Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 20 Europe Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 21 U.K. Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 22 U.K. Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 23 U.K. Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 24 U.K. Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 25 Germany Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 26 Germany Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 27 Germany Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 28 Germany Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 29 France Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 30 France Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 31 France Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 32 France Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 33 Italy Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 34 Italy Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 35 Italy Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 36 Italy Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 37 Spain Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 38 Spain Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 39 Spain Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 40 Spain Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 41 Asia Pacific Equine Healthcare market, by country, 2017 - 2030 (USD Million)
  • Table 42 Asia Pacific Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 43 Asia Pacific Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 44 Asia Pacific Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 45 Asia Pacific Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 46 China Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 47 China Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 48 China Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 49 China Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 50 Japan Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 51 Japan Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 52 Japan Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 53 Japan Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 54 India Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 55 India Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 56 India Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 57 India Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 58 Australia Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 59 Australia Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 60 Australia Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 61 Australia Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 62 South Korea Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 63 South Korea Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 64 South Korea Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 65 South Korea Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 66 Latin America Equine Healthcare market, by country, 2017 - 2030 (USD Million)
  • Table 67 Latin America Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 68 Latin America Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 69 Latin America Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 70 Latin America Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 71 Brazil Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 72 Brazil Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 73 Brazil Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 74 Brazil Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 75 Mexico Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 76 Mexico Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 77 Mexico Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 78 Mexico Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 79 Argentina Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 80 Argentina Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 81 Argentina Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 82 Argentina Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 83 MEA Equine Healthcare market, by country, 2017 - 2030 (USD Million)
  • Table 84 MEA Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 85 MEA Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 86 MEA Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 87 MEA Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 88 South Africa Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 89 South Africa Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 90 South Africa Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 91 South Africa Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 92 Saudi Arabia Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 93 Saudi Arabia Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 94 Saudi Arabia Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 95 Saudi Arabia Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 96 Global Equine Healthcare market, by region, 2017 - 2030 (USD Million)
  • Table 97 Global Equine Healthcare market, by Product, 2017 - 2030 (USD Million)
  • Table 98 Global Equine Healthcare market, by Indication, 2017 - 2030 (USD Million)
  • Table 99 Global Equine Healthcare market, by Activity, 2017 - 2030 (USD Million)
  • Table 100 Global Equine Healthcare market, by Distribution Channel, 2017 - 2030 (USD Million)
  • Table 101 Global Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 102 North America Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 103 U.S. Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 104 Canada Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 105 Europe Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 106 U.K. Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 107 Germany Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 108 France Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 109 Italy Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 110 Spain Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 111 Asia Pacific Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 112 Japan Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 113 China Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 114 India Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 115 Australia Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 116 South Korea Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 117 Latin America Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 118 Brazil Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 119 Mexico Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 120 Argentina Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 121 MEA Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 122 South Africa Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)
  • Table 123 Saudi Arabia Products market, by Pharmaceuticals, 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Equine Healthcare Market Revenues, 2021, (USD Millions)
  • Fig. 11 Parent market outlook
  • Fig. 12 Ancillary market outlook
  • Fig. 13 Penetration & growth prospect mapping by activity, 2021
  • Fig. 14 Market trends & outlook
  • Fig. 15 Market driver relevance analysis
  • Fig. 16 Market restraint relevance analysis
  • Fig. 17 Equine Healthcare market Product outlook: Key takeaways
  • Fig. 18 Equine Healthcare market: Product movement analysis
  • Fig. 19 Global Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 20 Global Pharmaceuticals market, 2017 - 2030 (USD Million)
  • Fig. 21 Global Parasiticides market, 2017 - 2030 (USD Million)
  • Fig. 22 Global Anti-infectives market, 2017 - 2030 (USD Million)
  • Fig. 23 Global Anti-inflammatory & Analgesics market, 2017 - 2030 (USD Million)
  • Fig. 24 Global Other Pharmaceuticals market, 2017 - 2030 (USD Million)
  • Fig. 25 Global Medicinal Feed Additives market, 2017 - 2030 (USD Million)
  • Fig. 26 Global Diagnostics market, 2017 - 2030 (USD Million)
  • Fig. 27 Global Software & Services market, 2017 - 2030 (USD Million)
  • Fig. 28 Global Others market, 2017 - 2030 (USD Million)
  • Fig. 29 Equine Healthcare market Indication outlook: Key takeaways
  • Fig. 30 Equine Healthcare market: Indication movement analysis
  • Fig. 31 Global Musculoskeletal Disorders market, 2017 - 2030 (USD Million)
  • Fig. 32 Global Parasite Control market, 2017 - 2030 (USD Million)
  • Fig. 33 Global Internal Medicine market, 2017 - 2030 (USD Million)
  • Fig. 34 Global Equine Herpes virus market, 2017 - 2030 (USD Million)
  • Fig. 35 Global Equine Encephalomyelitis market, 2017 - 2030 (USD Million)
  • Fig. 36 Global Equine Influenza market, 2017 - 2030 (USD Million)
  • Fig. 37 Global West Nile Virus market, 2017 - 2030 (USD Million)
  • Fig. 38 Global Tetanus market, 2017 - 2030 (USD Million)
  • Fig. 39 Global Others market, 2017 - 2030 (USD Million)
  • Fig. 40Equine Healthcare market Activity outlook: Key takeaways
  • Fig. 41Equine Healthcare market: Activity movement analysis
  • Fig. 42 Global Sports/Racing market, 2017 - 2030 (USD Million)
  • Fig. 43 Global Recreation market, 2017 - 2030 (USD Million)
  • Fig. 44 Global Others market, 2017 - 2030 (USD Million)
  • Fig. 45 Equine Healthcare market Distribution Channel outlook: Key takeaways
  • Fig. 46 Equine Healthcare market: Distribution Channel movement analysis
  • Fig. 47 Global Veterinary Hospitals & Clinics market, 2017 - 2030 (USD Million)
  • Fig. 48 Global E-Commerce market, 2017 - 2030 (USD Million)
  • Fig. 49 Global Others market, 2017 - 2030 (USD Million)
  • Fig. 50 Regional outlook, 2021 & 2030
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 North America Equine Healthcare market by countries, 2017 - 2030 (USD Million)
  • Fig. 53 U.S. Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 54 Canada Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 55 Europe Equine Healthcare market by countries, 2017 - 2030 (USD Million)
  • Fig. 56 U.K. Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 57 Germany Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 58 France Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 59 Italy Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 60 Spain Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 61 Asia Pacific Equine Healthcare market by countries, 2017 - 2030 (USD Million)
  • Fig. 62 Japan Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 63 China Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 64 India Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 65 Australia Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 66 South Korea Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 67 Latin America Equine Healthcare market by countries, 2017 - 2030 (USD Million)
  • Fig. 68 Brazil Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 69Mexico Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 70 Argentina Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 71 MEA Equine Healthcare market by countries, 2017 - 2030 (USD Million)
  • Fig. 72 South Africa Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia Equine Healthcare market, 2017 - 2030 (USD Million)
  • Fig. 74 Market Participant Categorization
  • Fig. 75 Equine Healthcare: Heat Map Analysis